Try our Advanced Search for more refined results
United States of America v. Walmart Inc. et al
Case Number:
1:20-cv-01744
Court:
Nature of Suit:
Judge:
Firms
Companies
- National Association of Chain Drug Stores
- National Retail Federation Inc.
- Walmart Inc.
- Washington Legal Foundation
Sectors & Industries:
- 
						March 11, 2024
						Walmart Fails To Sink Feds' Opioid Crisis LawsuitA Delaware federal judge on Monday kept alive a government lawsuit accusing Walmart of fueling the nation's opioid crisis, ruling that the company could be held liable for filling illegitimate prescriptions its compliance officers allegedly failed to flag for unwitting pharmacists. 
- 
						June 27, 2023
						Supreme Court's Opioid Edict Spawns 'Troubling' DivisionsAgainst long odds, two doctors facing decades in prison implored the U.S. Supreme Court to harmonize jury instructions in opioid crisis prosecutions, insisting that innocence in one circuit could be guilt in another. They ultimately prevailed, but one year later, the circuit split surprisingly appears even starker, as one of the doctors eyes freedom, and the other still might live out his life behind bars. 
- 
						February 17, 2023
						Walmart Rejects Opioid Liability Over 'Unwitting' PharmacistsWalmart is urging a Delaware federal judge to dump much of the U.S. Department of Justice lawsuit targeting the big-box retailer's sales of prescription opioids, arguing that the government can't pin liability on Walmart for pharmacists who unknowingly filled allegedly invalid prescriptions. 
- 
						January 18, 2023
						Walmart Aims To 'Weaken' Opioid Script Laws, DOJ SaysThe government urged a Delaware federal judge Tuesday to deny Walmart's attempt to escape much of the U.S. Department of Justice lawsuit targeting the big-box retailer's sales of prescription opioids, arguing that Walmart's narrow interpretation of the law would "weaken" the Controlled Substances Act and allow companies to skirt reporting obligations. 
- 
						December 16, 2022
						Leading Conservative Atty Retires After Decades At Jones DayMichael Carvin, the brusque, cigar-chomping attorney best known for forcefully championing conservative causes in the Supreme Court, is retiring after more than 20 years at Jones Day. 
- 
						November 07, 2022
						Walmart Rips 'Monday-Morning Quarterbacking' In Opioid SuitWalmart is asking a Delaware federal judge to throw out most of a U.S. Department of Justice lawsuit targeting the big-box retailer's sales of prescription opioids, saying the latest version of the case is far too broad. 
- 
						October 11, 2022
						DOJ Overhauls Walmart Opioid Suit After High Court DecreeAmid the U.S. Supreme Court's new standards for Controlled Substances Act cases, the U.S. Department of Justice is striving to salvage a sweeping suit targeting Walmart's sales of prescription narcotics, insisting that company officials "routinely ignored" their own suspicions about opioid orders. 
- 
						November 22, 2021
						DOJ-Walmart Opioid Battle Halted As High Court Reviews CSAThe U.S. Department of Justice's sweeping lawsuit contending that Walmart's 5,000 pharmacies "helped fuel a national crisis" of opioid abuse is being halted until the U.S. Supreme Court decides newly accepted cases involving the boundaries of Controlled Substances Act enforcement, a Delaware federal judge ruled. 
- 
						May 11, 2021
						Walmart Wants 5th Circ. To Revive Opioid Suit Against FedsWalmart Inc. has asked the Fifth Circuit to resurrect its lawsuit against the U.S. Department of Justice in which the retail giant sought a declaration that its prescription opioid sales are lawful, arguing that pre-enforcement review is a standard route for entities looking to clarify the scope of the law without waiting to be sued. 
- 
						March 04, 2021
						DOJ's 'Troubling' Theory Gains Walmart Allies In Opioid CaseBusiness groups, a pro-business think tank and a drug store advocacy group have backed Walmart's attempt to torpedo the federal government's suit claiming the retail chain helped spur the nationwide opioid epidemic by failing to scrutinize suspicious prescriptions. 
